Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The natural history of HIV-1 infection in Africa

Despite most of the available evidence pointing to the contrary, it remains a popular misconception that AIDS in Africa is a distinct disease from that suffered in industrialized nations.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Colebunders, R. et al. Seroconversion rate, mortality and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire. J. Infect. Dis. 164, 450–456 (1991).

    Article  CAS  Google Scholar 

  2. N'Galy, B. et al. Human immunodeficiency virus infection among employees in an African hospital. N. Engl. J. Med. 319, 1123–1127 (1988).

    Article  CAS  Google Scholar 

  3. Whittle, H. et al. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. AIDS 6, 685–689 (1992).

    Article  CAS  Google Scholar 

  4. Mann, J.M. et al. Natural history of human immunodeficiency virus infection in Zaire. Lancet 2, 707–709 (1986).

    Article  CAS  Google Scholar 

  5. Marlink, R. et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265, 1587–1590 (1994).

    Article  CAS  Google Scholar 

  6. Leroy, V. et al. Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988–1993. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 9, 415–421 (1995).

    Article  CAS  Google Scholar 

  7. French, N. et al. Immunological and clinical stages in HIV-1 infected adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 22, 509–516 (1999).

    Article  CAS  Google Scholar 

  8. Morgan, D. et al. Natural history of HIV infection in rural Uganda—results after 10 years. Abstract TuOr428. XIII International AIDS Conference, Durban 9–14 July 2000.

  9. UNAIDS. Report on the global HIV/AIDS epidemic, June 2000. Geneva 2000

  10. Hendriks, J.C.M. et al. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data accounting for death prior to an AIDS diagnosis. AIDS 12, 1537–1544 (1998).

    Article  CAS  Google Scholar 

  11. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active retroviral therapy: a collaborative re-analysis. Lancet 355, 1131–1137 (2000).

  12. Koblin, B.A. et al. Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978–1995. Am. J. Epidemiol. 150, 1026–1030 (1999).

    Article  CAS  Google Scholar 

  13. van Benthem, B.H.B. et al. Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental seroconvertor study. AIDS 12, 1039–1045 (1998).

    Article  CAS  Google Scholar 

  14. Touloumi, G. et al. Determinants of progression of HIV infection in a Greek Haemophilia cohort followed for up to 16 years after seroconversion. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 19, 89–97 (1998).

    Article  CAS  Google Scholar 

  15. World Health Organization. Acquired immunodeficiency syndrome. WHO/CDC case definition for AIDS. Wkly. Epidemiol. Rec. 61, 69–72 (1986).

  16. World Health Organization. Acquired immunodeficiency syndrome (AIDS). Interim proposal for a WHO staging system for HIV infection and disease. Wkly. Epidemiol. Rec. 65, 221–228 (1990).

  17. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb. Mortal. Wkly. Rep. 41 (RR-17), 1–19 (1992).

  18. Anzala, O.A. et al. Rapid progresion to disease in African sex workers with human immunodeficiency virus type 1 infection. J. Infect. Dis. 171, 686–689 (1995).

    Article  CAS  Google Scholar 

  19. Bwayo, J.J. et al. Comparison of the declines in CD4 counts in HIV-1-seropositive female sex workers and women from the general population in Nairobi, Kenya. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 10, 457–461 (1995)

    Article  CAS  Google Scholar 

  20. Anzala, A.O. et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J. Infect. Dis. 182, 59–66 (2000).

    Article  Google Scholar 

  21. Morgan, D. et al. Survival by AIDS defining condition in rural Uganda. Sex. Transm. Infect. 76, 193–197 (2000).

    Article  CAS  Google Scholar 

  22. Friedland, G.H. et al. Survival differences in patients with AIDS. J. Acquir. Immune Defic. Syndr. 4, 144–153 (1991).

    CAS  PubMed  Google Scholar 

  23. Lemp, G.F. et al. Survival trends for patients with AIDS. JAMA 263, 402–406 (1990).

    Article  CAS  Google Scholar 

  24. Moore, R.D. et al. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N. Engl. J. Med. 324, 1412–1416 (1991).

    Article  CAS  Google Scholar 

  25. Rogers, P.A. et al. Survival of adults with AIDS in the United Kingdom. Commun. Dis. Rep. Rev. 7, R93–R100 (1997).

    CAS  Google Scholar 

  26. Ghirardini, A. et al. Survival after AIDS among Italian haemophiliacs with HIV infection. The Italian Group on Congenital Coagulopathies. AIDS 9, 1351–1356 (1995).

    Article  CAS  Google Scholar 

  27. Mouton, Y. et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 11, F101–105 (1997).

    Article  CAS  Google Scholar 

  28. Moore, R.D. & Chaisson R.E. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 13, 1933–1942 (1999).

    Article  CAS  Google Scholar 

  29. Whalen, C. et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N. Engl. J. Med. 337, 801–808 (1997).

    Article  CAS  Google Scholar 

  30. Anglaret, X. et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1 infected adults in Abidjan, Côte d'Ivoire: a randomised trial. The Co-trimo-CI study group. Lancet 353, 1463–1468 (1999).

    Article  CAS  Google Scholar 

  31. Wiktor, S.Z. et al. Efficacy of trimethoprim-sulphamethoxazole chemoprophylaxis to decrease morbidity and mortality in HIV-1 associated tuberculosis in Côte d'Ivoire: a randomised controlled trial. Lancet 353, 1469–1475 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morgan, D., Whitworth, J. The natural history of HIV-1 infection in Africa. Nat Med 7, 143–145 (2001). https://doi.org/10.1038/84564

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/84564

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing